Corium International, Inc.
(NASDAQ : CORI)

( )
CORI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.45%185.151.2%$602.67m
CELGCelgene Corporation
-0.43%78.801.2%$532.62m
GILDGilead Sciences, Inc.
-0.63%71.070.9%$518.63m
BIIBBiogen Inc.
-0.44%296.041.2%$437.32m
NKTRNektar Therapeutics
-5.39%52.855.6%$412.99m
SRPTSarepta Therapeutics, Inc.
-6.23%140.3316.6%$356.37m
VRTXVertex Pharmaceuticals Incorporated
1.67%159.191.9%$269.27m
REGNRegeneron Pharmaceuticals, Inc.
0.89%331.972.6%$248.01m
ILMNIllumina, Inc.
-1.19%282.653.5%$212.82m
BLUEBluebird Bio, Inc.
-9.85%168.9015.7%$194.29m
EXASExact Sciences Corporation
-3.62%66.3325.4%$180.98m
AAgilent Technologies, Inc.
-0.40%62.791.5%$178.44m
ALXNAlexion Pharmaceuticals, Inc.
1.40%127.572.0%$159.93m
BMRNBioMarin Pharmaceutical Inc.
0.61%99.034.4%$141.99m
INCYIncyte Corporation
2.12%74.032.5%$133.28m

Company Profile

Corium International, Inc. is a commercial stage biopharmaceutical company, which develops, manufactures and commercializes pharmaceutical products. The company development platforms enable transdermal delivery of large molecules or biologics, including vaccines, peptides and proteins, as well as small molecules that are otherwise difficult to deliver in a transdermal dosage form. The firm offers its products under the brands Corplex and MicroCor. Corium International was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA.